Welcome to Central Library, SUST

Bioactive heterocyclic compound classes : (Record no. 63620)

MARC details
000 -LEADER
fixed length control field 05845cam a2200721Ia 4500
001 - CONTROL NUMBER
control field sulb-eb0031968
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221316.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120821s2012 gw ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency N$T
Language of cataloging eng
Description conventions pn
Transcribing agency N$T
Modifying agency YDXCP
-- UKMGB
-- OCLCQ
-- COO
-- OCLCQ
-- CUS
-- DG1
-- OCLCF
-- MHW
-- EBLCP
-- CDX
-- DEBSZ
-- OCLCQ
-- DEBBG
-- BD-SySUS
066 ## - CHARACTER SETS PRESENT
Alternate G0 or G1 character set (S
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 016099779
Source Uk
019 ## -
-- 809775189
-- 811005776
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783527664481
Qualifying information (electronic bk.)
International Standard Book Number 3527664483
Qualifying information (electronic bk.)
International Standard Book Number 3527333959
International Standard Book Number 9783527664450
International Standard Book Number 3527664459
International Standard Book Number 9783527333950
International Standard Book Number 9781283571432
Qualifying information (MyiLibrary)
International Standard Book Number 1283571439
Qualifying information (MyiLibrary)
International Standard Book Number 9783527664450
Qualifying information (electronic bk.)
Canceled/invalid ISBN 9783527333950
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000050193180
OCLC library identifier CHBIS
System control number 010026781
OCLC library identifier CHVBK
System control number 306231409
OCLC library identifier DEBSZ
System control number 431210055
OCLC library identifier NZ1
System control number 15915034
OCLC library identifier DEBBG
System control number BV043394991
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)807252111
Canceled/invalid control number (OCoLC)809775189
-- (OCoLC)811005776
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QD400
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI
Subject category code subdivision 013040
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 547.59
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Bioactive heterocyclic compound classes :
Remainder of title pharmaceuticals /
Statement of responsibility, etc. edited by Jürgen Dinges and Clemens Lamberth.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Weinheim :
Name of publisher, distributor, etc. Wiley-VCH ;
Place of publication, distribution, etc. Chichester :
Name of publisher, distributor, etc. John Wiley [distributor],
Date of publication, distribution, etc. 2012.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xv, 356 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
520 ## - SUMMARY, ETC.
Summary, etc. This volume presents important pharmaceuticals. Each of the around 20 chapters covers in a concise manner one class of heterocycles, clearly structured as follows:* Structural formulas of most important examples (market products)* Short background of history or discovery* Typical syntheses of important examples* Mode of action* Characteristic biological activity* Structure-activity relationship* Additional chemistry information (e.g. further transformations, alternative syntheses, metabolic pathways, etc.)* References. A valuable one-stop reference source for researchers in academia and industr.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Heterocyclic compounds.
Topical term or geographic name as entry element Pharmaceutical chemistry.
Topical term or geographic name as entry element SCIENCE
General subdivision Chemistry
-- Organic.
Source of heading or term bisacsh
Topical term or geographic name as entry element Heterocyclic compounds.
Source of heading or term fast
Authority record control number (OCoLC)fst00955736
Topical term or geographic name as entry element Pharmaceutical chemistry.
Source of heading or term fast
Authority record control number (OCoLC)fst01060115
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lamberth, Clemens.
Personal name Dinges, Jurgen.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Bioactive heterocyclic compound classes.
Place, publisher, and date of publication Weinheim : Wiley-VCH ; Chichester : John Wiley [distributor], 2012
International Standard Book Number 9783527333950
Record control number (OCoLC)807249672
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527664450">http://onlinelibrary.wiley.com/book/10.1002/9783527664450</a>
Public note Wiley Online Library [Free Download only for SUST IP]
880 0# - ALTERNATE GRAPHIC REPRESENTATION
Linkage 505-00/(S
a Introduction. The significance of heterocycles for pharmaceuticals and agrochemicals / Clemens Lamberth, Jürgen Dinges -- Neurological disorders. Tropane-based alkaloids as muscarinic antagonists for the treatment of asthma, obstructive pulmonary disease, and motion sickness / Michael L Schulte, Craig W Lindsley ; Morphinone-based opioid receptor agonist analgesics / Stephanie M Ng ; Barbituric acid-based GABA(A) receptor modulators for the treatment of sleep disorder and epilepsy and as anesthetics / Ingo Janser, Romy Janser ; Phenothiazine-based dopamine D antagonists for the treatment of schizophrenia / Cristiana A Zaharia ; Arylpiperazine-based 5-HT receptor partial agonists and 5-HT antagonists for the treatment of autism, depression, anxiety, psychosis, and schizophrenia / Irini Akritopoulou-Zanze ; Arylpiperidine-based dopamine D antagonists/5-HT antagonists for the treatment of autism, depression, schizophrenia, and bipolar disorder / Ying Wang ; Dibenzazepine-based sodium channel blockers for the treatment of neuropathic pain / Derek W Nelson -- Cardiovascular diseases. Dihydropyridine-based calcium channel blockers for the treatment of angina pectoris and hypertension / Milan Bruncko ; Tetrazole-based angiotensin II type 1 (AT) antagonists for the treatment of heart failure and congestive hypertension / Edward C Lawson, Brian C Shook, James C Lanter ; Thiazide-based diuretics for the treatment of hypertension and genitourinary disorders / Jürgen Dinges ; Tetrahydropyranone-based HMG-CoA reductase inhibitors for the treatment of arterial hypercholesterolemia / Hongyu Zhao -- Infectious diseases. Adenine-based reverse transcriptase inhibitors as anti-HIV agents / Alastair Donald ; Guanine-based nucleoside analogs as antiviral agents / Maurizio Franzini ; Penicillin and cephalosporin antibiotics / Michael Z Hoemann -- Oncology. Pyrimidine-based kinase inhibitors in cancer chemotherapy / Robert Mah ; Benzyl triazole-based aromatase inhibitors for the treatment of breast cancer / Dawn George, Stacy Van Epps -- Inflammation and gastrointestinal diseases. Acetonide-based glucocorticoids for the treatment of asthma, skin inflammation, and diseases of the eye / Kevin P Cusack, Vikram G Kalthod, Rajarathnam E Reddy, Sanjay R Chemburkar ; Benzimidazole-based H/K-ATPase inhibitors for the treatment of gastroesophageal reflux disease / Steve Swann -- Metabolic diseases. Thiazolidinedione-based insulin sensitizers: PPAR-γ agonists for the treatment of type 2 diabetes / Steven Richards -- Index.
938 ## -
-- Coutts Information Services
-- COUT
-- 23224048
-- 115.00 GBP
-- EBL - Ebook Library
-- EBLB
-- EBL999416
-- EBSCOhost
-- EBSC
-- 476673
-- YBP Library Services
-- YANK
-- 9592267
-- YBP Library Services
-- YANK
-- 9985375
994 ## -
-- 92
-- DG1

No items available.